Credits: Canva
Is there a new pandemic lingering over us? Is Japan at the brink of declaring a health epidemic? After the COVID-19 pandemic, this question has been looming over everyone for a while now. However, it is an undeniable fact that with climate change, illness are now staying all round the year, talking about the COVID-19 virus specifically, it too has now become a seasonal-like virus. However amid this, Japan has declared a nationwide flu outbreak, which has a high rise in hospitalization, school closures and has left public healthcare system under a lot of pressure.
As per the media reports in Japan, the Health Ministry has confirmed the national average has surpassed the epidemic threshold reaching 1.04 patients per medical institution.
Typically, Japan's flu season is in late November or December, however, this year, it seems to have arrived sooner.
The Health Ministry also noted on October 3 that more than 4,000 people have been hospitalized with influenza and that there was a four-fold increase seen in Japan in the previous week. As of now, 28 of the 47 prefectures in Japan has reporting rise in cases, especially in Tokyo, Okinawa and Kagoshima. It has forced over 130 schools and childcare centers to close. Okinawa reported the highest numbers.
Read: Covid, Cold, Or Flu: How To Differentiate Between These Infections?
Similar trends have been reported in Singapore, Thailand, and India. In northern India, the H3N2 strain—descended from the 1968 Hong Kong flu virus, has been spreading, while Thailand recorded more than half a million flu cases this year with 59 deaths. Singapore also saw a steady rise in flu and respiratory infections as inter-monsoon rains forced people indoors.
Experts suggest that changes in weather patterns, global travel, and evolving viral strains could be contributing to these early and frequent outbreaks. Warmer climates and extreme weather may be influencing how and when flu viruses spread, with studies hinting that heavy rainfall and higher humidity could drive people indoors, creating ideal conditions for transmission. Climate change could also affect virus survival and migration patterns of wild birds, further influencing outbreaks.
The World Health Organization’s (WHO) latest vaccine guidelines for the Southern Hemisphere introduced new H1N1 and H3N2 strains, indicating that mutated versions are circulating. Experts are particularly monitoring subtypes like H5, H7, and H9 in animals, as new strains could potentially trigger another pandemic similar to the 1957 H2N2 “Asian Flu.” The recent detection of bird flu strains in mammals has raised further concerns about possible cross-species mutations.
While there’s no evidence that influenza viruses are mutating faster than before, experts agree the virus continues to evolve in ways that challenge immunity from previous infections or vaccines. Regular flu vaccination remains the best defense, especially for the elderly and vulnerable. Experts also stress the need for better awareness, improved hygiene practices, and policies that discourage working while sick. A universal flu vaccine that covers multiple strains could offer a long-term solution—but it’s still in development.
Credit: Canva
Schizophrenia (SCZ), bipolar disorder (BD) and major depressive disorder may share the same genetic roots, a Nature study shows.
While experts have long classified each of these mental disorders as individual illnesses with their own causes, researchers from across China have discovered that these three diseases share about 70 percent common genetic and environmental risk factors.
Schizophrenia is a severe, chronic brain disorder that can lead psychosis, hallucinations, delusions, disorganized thinking and reduced emotional expression. It can affect how a person's thinks, feels and behaves, making it hard to distinguish reality.
While bipolar disorder is a chronic mental illness which causes extreme mood swings, from emotional highs (mania/hypomania) to lows (depression), affecting the brain's energy, activity and focus levels.
On the other hand, major depressive disorder or clinical depression, is a serious mood disorder that causes persistent sadness and loss of interest in a person. It can affect feelings, thoughts and daily activities and can be identified by symptoms such as low energy, sleep/appetite changes, guilt, concentration issues and thoughts of death.
Using advanced techniques, they identified 238 genetic variants that raise risk across multiple disorders and showed that five major genetic patterns explain most of the differences between people with and without mental illness.
Read More: Study Shows Depression Can Accelerate The Onset Of Chronic Illnesses
Based on these genetic patterns, the disorders clustered into five broad groups: internalizing conditions such as depression, anxiety and post-traumatic stress disorder; neurodevelopmental conditions including autism and attention-deficit hyperactivity disorder; substance use disorders; compulsive conditions such as obsessive-compulsive disorder and anorexia and lastly, a fifth group that included bipolar disorder and schizophrenia.
The findings explain why many individuals are diagnosed with more than one mental health condition as many genes affect multiple brain pathways. This indicates that the same genetic changes can lead to different disorders depending on other biological and environmental factors.
Even though medications such as antidepressants are useful in treating multiple mental illnesses including depression, anxiety and PTSD, the researchers concluded that more research is needed to understand the biology behind the genetic factors to understand the links between the disease.
One of the study’s authors compared the current system to diagnosing a patient with separate illnesses for a cough, sore throat and runny nose instead of recognizing a single underlying infection.
Nearly one in eight people globally, around 970 million individuals, were living with a mental disorder in 2021, with anxiety and depression being the most common globally.
Credit: Canva
Amazon has confirmed that 10 employees at its Coventry, UK warehouse have tested positive for tuberculosis (TB) as calls for site shutdown continue to grow.
Cases emerged at the hub, which has about 3,000 employees, in September 2025 and were found to be non-contagious. However, the retail giant acknowledged the breakout on January 16.
Officials from Amazon noted: "In line with best practice safety procedures, we immediately followed guidance from the NHS and UK Health Security Agency (UKHSA) and made all potentially affected employees aware of the situation. Out of an abundance of caution, we are currently running an expanded screening program with the NHS.
"We will continue to follow guidance from the experts in the NHS, and would respectfully remind public organizations of the need for responsible communications where matters of public wellbeing are concerned."
A spokesperson also assured that no new cases have been recorded in the area and a "screening program" being carried out amid "an abundance of caution" in collaboration with NHS and the UK Health Security Agency (UKHSA).
Since being diagnosed with TB, the unidentified patients have been receiving treatment from the UKHSA in West Midlands. Dr Roger Gajraj, consultant in health protection with UKHSA West Midlands also revealed that tests are being offered to those who may have had close contact with the patients and assured the overall risk remains low.
He told the BBC: "The small number of individuals affected by tuberculosis (TB) are responding well to treatment and are no longer infectious, so pose no onward risk.
"As a precaution, and in line with national guidance, we are offering testing to those who may have had closer contact with the affected individuals. The overall risk remains low. TB is fully treatable with antibiotics. We continue to work closely with Amazon to monitor the situation."
Read More: WHO’s Latest TB Guidelines Highlight Nutrition as Key to Treatment
Common signs and symptoms of TB include unexplained weight loss, loss of appetite, chills and fever, fatigue, getting night sweats, weakness or fatigue. Symptoms of TB disease in the lungs may include coughing up blood or sputum, a cough lasting for more than 3 weeks and chest pain.
TB is typically diagnosed through the Mantoux Tuberculin Skin Test(TST). Here, a small amount of tuberculin is injected into the skin of the forearm and is monitored for a reaction 48 to 72 hours after the injection. A positive skin test result indicates the presence of TB and there is a need for additional tests to determine to determine if it is active or latent.
If positive, blood tests are done to determine or rule out if the patient has active or latent TB. There are two blood tests approved by the Food and Drug Administration for TB- T-SPOT TB test(T-spot) and the QuantiFERON-TB Gold-In-Tube test(QFT-GIT). Doctors may also prescribe a chest X-ray or CT scan after a positive skin test.
Despite being preventable through vaccine and and curable through antibiotics, TB remains a leading infectious killer and causes over a million deaths annually worldwide, with millions falling ill each year.
In 2024, about 10.7 million people were diagnosed with TB out of which 1.23 million died from the disease.
Credits: Canva
The Tamil Nadu government has prohibited the manufacture, sale, distribution, and use of the cough syrup Almond Kit after laboratory testing confirmed it contained the highly toxic chemical ethylene glycol, according to a press release issued by the state’s drug control authority. Officials said the syrup, which is produced in Bihar, was found to be contaminated with ethylene glycol, a substance known to trigger serious and, in some cases, fatal health problems. But what exactly is ethylene glycol poisoning, and what health conditions can it cause?
The Tamil Nadu government has imposed a complete ban on the manufacture, sale, distribution, and consumption of the cough syrup Almond Kit after laboratory tests detected the presence of ethylene glycol, a highly dangerous chemical, the state drug control department said in a press statement. Citing news agency IANS, officials confirmed that the syrup is manufactured in Bihar and was found to be contaminated with ethylene glycol, a compound associated with severe and sometimes life-threatening health complications.
Ethylene glycol is a colourless, odourless liquid with a sweet taste, most commonly used in antifreeze. It may be consumed accidentally or intentionally, including in cases of self-harm. Once inside the body, ethylene glycol breaks down into glycolic acid and oxalic acid, which are responsible for most of its toxic effects.
According to Medline Plus, early symptoms of ethylene glycol poisoning include a feeling of intoxication, nausea, vomiting, and abdominal pain. As the poisoning progresses, symptoms can worsen and may include reduced consciousness, headaches, and seizures.
As per the US Centers for Disease Control and Prevention (CDC), exposure to ethylene glycol can result in severe and potentially fatal health conditions, particularly when ingested through contaminated medicines.
One of the most serious effects is acute kidney failure, which can develop rapidly and may cause the kidneys to shut down within a few days if treatment is delayed. Ethylene glycol can also harm the brain and nervous system, leading to confusion, poor coordination, seizures, and even coma.
The toxin can cause severe metabolic acidosis, a condition in which the blood becomes dangerously acidic, interfering with normal heart function and breathing.
In certain cases, ethylene glycol exposure can also lead to lung-related complications, including fluid accumulation in the lungs that makes breathing difficult.
Without prompt medical intervention, ethylene glycol poisoning can be fatal, especially in children and individuals with existing kidney or liver disease. This is why its detection in any oral medication is treated as a serious public health concern.
According to IANS, consumers have been advised to check for batch number AL24002 and strictly avoid using the syrup. People who already have the product have been asked to contact authorities for instructions on safe disposal. The Directorate has also stepped up inspections and monitoring across pharmacies and hospitals in Tamil Nadu to ensure the contaminated cough syrup is fully removed from circulation.
© 2024 Bennett, Coleman & Company Limited